1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Chronic Interstitial Cystitis: new trials by email Literature Review of Chronic Interstitial Cystitis trials Research Report on Chronic Interstitial Cystitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome AQX-1125 100 mg, AQX-1125 200 mg, Placebo - Interstitial Cystitis, Bladder Pain Syndrome | Phase 3 | Unknown | Aquinox Pharmaceuticals (Canada) Inc. | 433 | 2016-07-01 | 2018-03-15 |
Cystitis (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Urinary Bladder Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Aquinox Pharmaceuticals (Canada) Inc. (1)
Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · Hungary (1) · Latvia (1) · Netherlands (1) · Poland (1) · Romania (1) · Spain (1) · United Kingdom (1) · United States (1)